IMU 0.93% 5.4¢ imugene limited

Told you so!! IMU heading to $200m Mkt Cap, page-43

  1. 2,363 Posts.
    lightbulb Created with Sketch. 236
    Supertramp thanks for quoting me but you are not complete right IMO. The ASX does value certain biotech’s highly.

    Take for example CSL. Current price $155. Market cap circa $50 billion. For people lucky to have got this stock at the float price in the early 90’s circa $2. Taking into account the 3 way split the stock price is actually over $450. Not bad from $2 float!!!

    The difference is CSL is a bemoath with huge free cash flows, profits and global repute. The Aussie market values profit and cash flow in biotech’s.

    The US market is larger and more willing to put a higher value on specs. So, yes Imugene would have probably been valued higher in a US listed market.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
-0.001(0.93%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.5¢ 5.6¢ 5.4¢ $322.4K 5.911M

Buyers (Bids)

No. Vol. Price($)
28 3689604 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 1067155 22
View Market Depth
Last trade - 11.38am 30/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.